Skip to Content

Suboxone 16 mg / 4 mg Sublingual tablet

Licence status
Authorised: 26/09/2006
Active substances
Buprenorphine hydrochloride , Naloxone hydrochloride dihydrate
Dosage Form
Sublingual tablet
Licence number
EU/1/06/359/005-006
Licence holder
Indivior Europe Limited

Licence information

ATC code
N07BC Drugs used in opioid dependence, N07BC51 buprenorphine, combinations
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2). This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/09/2006